Evaluation of Non-Invasive Tests for Metabolic Liver Disease | MicrobiomeTrials← Back to trialsNCT07122700
Evaluation of Non-Invasive Tests for Metabolic Liver Disease
RecruitingOBSERVATIONAL
Trial Details
Start: 2025-05-13Est. Completion: 2027-06-30
Enrollment target: 400 participants Locations- Clinical Pharmacology of Miami, Miami, Florida, United States
- Ohio Clinical Trials, Columbus, Ohio, United States
- First Surgical Hospital, Bellaire, Texas, United States
- Endeavor Clinical Trials, San Antonio, Texas, United States
Other microbiome trials you might be interested in
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
This study will test a Regeneron study drug called ALN-CIDEB to find out whether it may help treat a liver disease calle…
Tucson, United StatesEst. completion Jan 29, 2029
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseMASH - Metabolic Dysfunction-Associated SteatohepatitisLiver Fibrosis/NASH
The goal of this clinical trial is to learn how physical exercise affects liver health in adults with metabolic dysfunct…
Madrid, SpainEst. completion Jun 2027